The canagliflozin and renal endpoints in diabetes with established nephropathy clinical evaluation (CREDENCE) study rationale, design, and baseline characteristics

Jardine Meg J., Mahaffey Kenneth W., Neal Bruce, Agarwal Rajiv, Bakris George L., Brenner Barry M., Kollaborációs szervezet: CREDENCE study investigators, Csecsei Gyöngyi, Csiky Botond, Danos Péter, Deák László, Dudás Mihály, Keltai Katalin, Takács Róbert, Rosivall László, et al
2017